跳至主要内容
临床试验/CTRI/2024/08/071834
CTRI/2024/08/071834尚未招募2/3 期

An exploratory single arm study on the efficacy of maha agad in the management of dushi visha janya artava kshaya (poly cystic ovarian syndrome )

Post Graduate Institute of Ayurved Jodhpur1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年8月20日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Reduction of ovarian cyst (size, volume & number).

研究概览

简要总结

Type of study : Interventional

Purpose : Treatment

Timing : Prospective

End point : Effectiveness/Therapy

Duration : 60 days

Sample size : 30

CRITERIA FOR SELECTION :      Patients will be selected from OPD and IPD of PGIA, Jodhpur and registered dispensary/hospital asper the criteria of inclusion strictly.

•                                                                     Written voluntary informed consent will be obtained from each patient before starting the trial.

The study will be completed on minimum 30 clinically diagnosed patients of PCOS.

POSOLOGY:   Maha Agad

Kalpana -Vati

Dose -2 Tab of 500 mg

Route of administration- Orally

Time of administration- 3 times a day after meal

Anupana -Luke warm water

Duration- 60 days

FOLLOWUP****STUDY

**1.**Follow up after 15 days completion of the trial will be in 60 days.

2.  Improvement and other effect will be noted.

3. Laboratory investigations will be repeated if seemed necessary.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Patient diagnosed cases of PCOS by the ROTTERDAM CRITERIA.
  • Patient with age group between 18-45 years.
  • Patient willing to give consent for clinical trial.
  • Patient having history of consuming Dushi Visha (as per mentioned in questionnaire) for a long period of time.

排除标准

  • Patient suffering from adrenal or ovarian tumor.
  • Patient suffering from cushing syndrome, congenital adrenal hyperplasia, hyperprolactinemia.
  • 3.Patient suffering from any systemic disorder and congenital disorder.
  • 4.Patient suffering from pelvic pathology including fibroid uterus, cervical polyp.
  • 5.Women taking oral contraceptive pills.

结局指标

主要结局

Reduction of ovarian cyst (size, volume & number).

时间窗: 60 Days

次要结局

  • Changes in the secondary objective.(1. Improvement in hormonal assay.)

研究者

发起方
Post Graduate Institute of Ayurved Jodhpur
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Sristi Purohit

Post Graduate Institute of Ayurved Jodhpur 342037

研究点 (1)

Loading locations...

相似试验